Researchers from Hong Kong and the U.S. have developed a new statistical and mapping method that could help identify drug targets for treating leukaemia.
In chronic myelogenous leukaemia (CML), too many stem cells in the bone marrow are transformed into a type of white blood cell called granulocytes, making less room for healthy white blood cells, red blood cells and platelets. CML occurs due to a chromosomal abnormality in which an abnormal gene is formed, called the BCR-ABL fusion gene. However, the development of CML is not fully understood, leading to limited treatment options.
The findings could help physicians develop more effective treatment strategies for chronic myelogenous leukaemia.
Copyright : Sebastian Kaulitzki
The BCR-ABL gene activates enzyme pathways that disrupt protein synthesis and cause uncontrolled cell growth. A better understanding of these pathways and how they are activated could lead to the discovery of drug targets for CML.
Past research has shown that the expression of a protein-coding gene called NPM1 changes in tumour cells. NPM1 was found to respond to signals from enzyme pathways initiated by the BCR-ABL gene.
Benjamin Yung’s research group at The Hong Kong Polytechnic University together with researchers from Harvard University in the U.S. and Queen Elizabeth Hospital in Hong Kong have developed a unique statistical and mapping strategy that identifies the relationships among those genes that are involved in the development of CML.
Using their unique statistical approach, the researchers quantified and analysed publicly available gene expression data of nine CML patients and eight healthy volunteers. They created networking maps from the data to facilitate the visualization of the connections among genes.
They compared NPM1 gene expressions with those from the BCR-ABL-initiated enzyme pathways in the CML patients and similar pathways that exist in healthy individuals. They also explored the role of NPM1 “doublets” – genes strongly co-expressed with NPM1 – in protein formation.
The researchers identified two sets of gene doublets that strongly co-expressed in CML patients but were not co-expressed in healthy individuals. These gene pairs may be related to CML development and thus could be an important target for drug research.
They also found that NPM1 established ten gene-expressing pairs with BCR-ABL pathways in CML patients but only two pairs with similar pathways in healthy individuals, which may mean that NPM1 mediates the activation of other cellular proliferation pathways in CML.
Finally, the researchers used a substance, called resveratrol, which is thought to have anti-cancer properties, on CML cells. Resveratrol caused a decrease in the expression of NPM1-related proteins and is thus a potential drug target for CML therapy.
The researchers’ findings could help physicians develop more effective treatment strategies for CML. Their statistical and mapping strategy can also be used to diagnose and develop treatments for other diseases.
For further information contact:
Professor Benjamin Yung
Department of Health Technology and Informatics
The Hong Kong Polytechnic University
The Hong Kong Polytechnic University | Research SEA
A Map of the Cell’s Power Station
18.08.2017 | Albert-Ludwigs-Universität Freiburg im Breisgau
On the way to developing a new active ingredient against chronic infections
21.08.2017 | Deutsches Zentrum für Infektionsforschung
Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.
As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...
Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.
Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...
For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.
While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...
An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.
The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...
A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.
Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...
16.08.2017 | Event News
04.08.2017 | Event News
26.07.2017 | Event News
21.08.2017 | Medical Engineering
21.08.2017 | Materials Sciences
21.08.2017 | Life Sciences